Ovid Therapeutics Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €487.64K +44.5% -€22.77M -49.5% -4,670.1% +87 pp -€48.15M +22.4% -9,873.7% +18 pp
    €337.46K -73.9% -€45.09M -3.4% -13,362.2% -98 pp -€39.32M -15.2% -11,652.8% -81 pp
    €1.29M -99.3% -€46.67M -144.1% -3,604.1% -37 pp -€46.36M -145.3% -3,580.1% -36 pp
    €179.53M +1,551.6% €105.83M -251.6% 58.9% +7.0 pp €102.35M -332.1% 57.0% +4.6 pp
    €10.87M +∞% -€69.82M +34.0% -642.3% -6.4 pp -€44.11M +0.7% -405.7% -4.1 pp
    €0.00 +NaN% -€52.09M +16.3% N/A -€43.81M +12.5% N/A
    €0.00 +NaN% -€44.78M -19.8% N/A -€38.95M +43.9% N/A
    €0.00 +NaN% -€55.83M +189.1% N/A -€27.07M +78.4% N/A
    €0.00 +NaN% -€19.31M +70.3% N/A -€15.17M +224.4% N/A
    €0.00 +NaN% -€11.34M +2,844.1% N/A -€4.68M +1,992.2% N/A
    €0.00 -€385.11K N/A -€223.57K N/A

    Notifications